Skip to main
ATR
ATR logo

Aptargroup (ATR) Stock Forecast & Price Target

Aptargroup (ATR) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AptarGroup has demonstrated strong growth potential, particularly through its AMS Solutions segment, which has been expanding at a compound annual growth rate (CAGR) of approximately 10%, contributing around 5% to total fiscal year 2024 revenue. The company's Injectables business has also exhibited significant growth at a 9% CAGR, supported by an evolving global drug pipeline trending towards biologics and increased demand for GLP-1 therapies. This dual growth in high-value products is anticipated to further enhance AptarGroup's profit margins, solidifying a positive financial outlook for the company.

Bears say

AptarGroup faces significant challenges that could negatively impact its financial performance, particularly in its transition to a majority Pharma segment which may be slower than anticipated, thereby limiting growth and margin expansion. The company's reliance on international markets exposes it to currency fluctuations and economic cycles, which can adversely affect industry demand and revenue stability. Furthermore, risks associated with regulatory inspections, potential facility shutdowns, shipping liabilities, increasing competition, and the protection of proprietary intellectual property further complicate AptarGroup's financial outlook.

Aptargroup (ATR) has been analyzed by 4 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aptargroup and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aptargroup (ATR) Forecast

Analysts have given Aptargroup (ATR) a Buy based on their latest research and market trends.

According to 4 analysts, Aptargroup (ATR) has a Buy consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $167.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $167.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aptargroup (ATR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.